Trial Profile
A Phase II Study of Ribociclib, A CDK4/6 Inhibitor, in Patients with Metastatic Castration-Resistant Prostate Cancer
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Apr 2015
Price :
$35
*
At a glance
- Drugs Ribociclib (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 02 Apr 2015 New trial record